Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints

Overview of attention for article published in Annals of Neurology, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 142,468 followers.

RT @ANA_journals: #REVIEWS: Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints https://t.co/8WdknkJdgE @TheNewANA…

#REVIEWS: Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints https://t.co/8WdknkJdgE @TheNewANA1 @WileyNeuro

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.